The following represents disclosure information provided by authors of this abstract. The Gastrointestinal Cancers Symposium Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
FOLFOX and nab-paclitaxel (nab-P) for advanced pancreatic cancer: A phase I study.
Howard Safran
No relevant relationships to disclose
Kevin Charpentier
No relevant relationships to disclose
Kimberly Perez
No relevant relationships to disclose
Kalyan Mantripragada
No relevant relationships to disclose
Trevor Clark Austin
No relevant relationships to disclose
Omar Nadeem
No relevant relationships to disclose
Alise Lombardo
No relevant relationships to disclose
Lindsay Houlihan
No relevant relationships to disclose
Lucia Fontes-Borts
No relevant relationships to disclose
Irene Kolberg
No relevant relationships to disclose
Kristen Mitchell
No relevant relationships to disclose
Kayla Rosati
No relevant relationships to disclose